obstructive sleep apnea, which is an added source of oxidative stress, through chronic intermittent hypoxia (CIH).
Detrimental effects of air pollution with fine dust (particulate matter <2.5 mm in aerodynamic diameter, or PM 2.5 ) on the systemic circulation and the left heart have been studied intensely during the past decade. In comparison, knowledge regarding the effects of exposure to air pollution with PM 2.5 on the pulmonary vasculature and the right heart lags far behind. A report on severe lung disease and right heart failure in coal miners was published nearly 170 years ago. However, today, we still do not have a clear picture of how the effect of air pollution on the pulmonary circulation or the right heart should be viewed from a clinical, mechanistic biological, therapeutic, or economic angle.
In the laboratory, we have established a model of immune response-induced vascular remodeling that is significantly worsened by adding PM 2.5 to the intranasal antigen challenge solution. Importantly, the PM 2.5 is given at a concentration that by itself does not induce significant inflammation or pulmonary vascular remodeling. However, when added to antigen, this low-dose PM 2.5 exposure induces severe pulmonary vascular remodeling, significantly increased right ventricular pressures, and significant molecular changes in the right heart. Our data also show that these PM 2.5 -exaggerated responses are dependent on interleukin-13, interleukin-17A, and antigen-specific antibody. The experimental model is being used to address a few questions: 1. Which mechanism protects the animals from severe right ventricular failure despite the severity of the pulmonary artery remodeling? 2. What is the mechanism by which PM 2.5 worsens the response to antigen? 3. How does PM 2.5 exert its effects across the small airways to the small blood vessels?
In conclusion, further investigation is urgently needed to understand the effects of exposure to ambient or occupational air pollution on the pulmonary vasculature, because better knowledge could lead to immediate beneficial actions for patients with pulmonary hypertension and persons at risk. Rationale: Smoking is a major risk factor for the development of cardiovascular and pulmonary diseases. The importance of the renin-angiotensin system in the development of cardiovascular and pulmonary disease is well established. Angiotensin-II, by means of its type 1 receptor (angiotensin type 1 receptor, AT 1 R), promotes increased sympathetic activity, salt and water reabsorption, vasoconstriction, inflammation, and aldosterone and vasopressin release, contributing to tissue fibrosis, endothelium dysfunction, and hypertension. Angiotensin-converting enzyme 2 cleaves angiotensin-II into the vasodilator peptide, angiotensin-(1-7), hence playing a pivotal role in the angiotensin-converting enzyme 2/ angiotensin-(1-7) compensatory axis of the renin-angiotensin system. Angiotensin type 2 receptor (AT 2 R), another receptor for angiotensin-II, opposes the deleterious effects of AT 1 R activation, and angiotensinconverting enzyme 2-formed angiotensin-(1-7) has been shown to activate AT 2 R.
Objectives: The goal of the present study was to examine how nicotine, the addictive component of cigarette smoke, alters the homeostasis of the renin-angiotensin system.
Methods: Quantitative real-time polymerase chain reaction was performed to examine the expression of the components of the renin-angiotensin system after cigarette smoke exposure or direct nicotine inhalation. Radio telemetry was used for continuous blood pressure recording in conscious, unrestrained mice.
Results: Our study showed that cigarette smoke or direct nicotine inhalation inhibits the expression of angiotensin-converting enzyme 2/AT 2 R in multiple organs and cell types. In the lung, cigarette smoke (6 cigarettes/d, 12 wk) inhibited the expression of both angiotensin-converting enzyme 2 and AT 2 R. In cardiac fibroblasts, nicotine exposure resulted in near complete suppression of angiotensin-converting enzyme 2 and AT 2 R. In the brain, nicotine vapor inhalation inhibited angiotensin-converting enzyme 2 expression in the hypothalamus, a region involved in central regulation of cardiopulmonary function. In addition, cultured Neuro2A cells exposed to nicotine showed a dosedependent reduction of enzymatic activity of angiotensinconverting enzyme 2. Functionally, mice exposed to nicotine vapor (12 h/d, 4 wk) exhibited significantly increased mean arterial blood pressure, which was more pronounced during the night active cycle (mean 6 SE, 124 6 0.6 mm Hg in nicotine vapor-exposed mice vs. 107 6 0.4 mm Hg in air control mice; P , 0.0001).
Conclusions: Our findings suggest that, by downregulating the compensatory angiotensin-converting enzyme 2/AT 2 R elements, nicotine disrupts the homeostasis of the reninangiotensin system in multiple organs, which is likely an important mechanism leading to the development of cardiovascular and pulmonary disease.
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